Koichiro Kumai
About
In The Last Decade
Koichiro Kumai
149 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 112
- Pulmonary and Respiratory Medicine 1.9k
- Surgery 1.3k
- Gastroenterology 1.2k
- Oncology 909
- Molecular Biology 475
Countries citing papers authored by Koichiro Kumai
This map shows the geographic impact of Koichiro Kumai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Kumai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Kumai more than expected).
Fields of papers citing papers by Koichiro Kumai
This network shows the impact of papers produced by Koichiro Kumai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Kumai. The network helps show where Koichiro Kumai may publish in the future.
Co-authorship network of co-authors of Koichiro Kumai
This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Kumai. A scholar is included among the top collaborators of Koichiro Kumai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Kumai. Koichiro Kumai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 39 | |
| 3 | 27 | |
| 4 | 12 | |
| 5 | 15 | |
| 6 | Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo. | 13 |
| 7 | 52 | |
| 8 | 69 | |
| 9 | 14 | |
| 10 | 15 | |
| 11 | 15 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 19 | |
| 17 | 0 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.